Daubert In Product Liability Cases: Mid-2017 Update, by Max Kennerly, Litigation & Trial
An excellent analysis of Daubert in 4 product liability cases from the federal circuit courts. -CCE
Today we’re going to review the state of the art, as it were, of Daubert in product liability cases by examining the four most recent published Court of Appeals opinions. Those opinions are:
- Adams v. Toyota Motor Corp., No. 15-2507, 2017 WL 2485204 (8th Cir. June 9, 2017)
- In re Zoloft (Sertraline Hydrochloride) Prod. Liab. Litig., 16-2247, 2017 WL 2385279 (3d Cir. June 2, 2017)
- Wendell v. GlaxoSmithKline LLC, No. 14-16321, 2017 WL 2381122 (9th Cir. June 2, 2017)
- Nease v. Ford Motor Co., 848 F.3d 219 (4th Cir. 2017)
Plaintiffs lost Zoloft and Nease, and won Adams and Wendell. But it would be foolish to look at these cases simply as a scorecard: the real issue here for future cases is how the courts decided the cases.
The Researching Paralegal 
You must be logged in to post a comment.